Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Income from Continuing Operations (2024 - 2025)

Beta Bionics (BBNX) has disclosed Income from Continuing Operations for 2 consecutive years, with 13466000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations fell 11.42% to 13466000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 60749000.0 through Dec 2025, down 46.94% year-over-year, with the annual reading at 60749000.0 for FY2025, 46.94% down from the prior year.
  • Income from Continuing Operations hit 13466000.0 in Q4 2025 for Beta Bionics, up from 14210000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 8314000.0 in Q1 2024 to a low of 16867000.0 in Q2 2025.